Latest News
Evaluating Changes in Biodesix’s VeriStrat Test over the Course of Treatment with Gefitinib
News Nov 11, 2011“Changes in plasma mass-spectral (VeriStrat) profile in course of treatment of NSCLC patients with EGFR-TKIs,” is published in the November issue of the Journal of Thoracic Oncology.
READ MORE
Lorus Presents Positive Data from Nonclinical Toxicity Studies on Lead Cancer Drug at Major Conference
News Nov 11, 2011Presentation of positive data for LOR-253 at the Annual Meeting of the American College of Toxicology.
READ MORE
ORCA Receives up to € 5 Million Innovation Credit from Dutch Government
News Nov 11, 2011Company receives credit to support development of ORCA-010 product for prostate cancer.
READ MORE
Researchers Identify Skin Cancer Genes
News Nov 10, 2011The genes which contribute to the most frequently occurring life threatening form of skin cancer have been identified for the first time.
READ MORE
Transgenomic and ScreenCell Announce Worldwide Distribution and Collaboration Agreement
News Nov 09, 2011The perpetual, worldwide collaboration and distribution agreement is for ScreenCell’s Isolation Devices and Dilution Buffers.
READ MORE
Convergence of Normal Stem Cell and Cancer Stem Cell Developmental Stage: Implication for Differential Therapies
News Nov 08, 2011Tumorigenesis is believed to have a critical "therapeutic window" identification of which is postulated to allow the production of more effective therapies to treat several cancers.
READ MORE
Cellceutix Files IND Application with FDA
News Nov 08, 2011Clinical trials planned at Dana-Farber/Harvard Cancer Center.
READ MORE
Oxford Gene Technology and Abcodia Form Partnership
News Nov 08, 2011Companies combine expertise to advance biomarkers for the early diagnosis of pancreatic cancer.
READ MORE
FEI and Oregon Health & Science University Announce Partnership
News Nov 04, 2011Partnership to create a ‘Living Lab for Cell Biology’ with high-performance electron microscopes for disease research.
READ MORE
Seattle Genetics and Oxford BioTherapeutics to Collaborate on ADCs for Cancer
News Nov 04, 2011Companies to combine proprietary technologies to generate novel ADC product candidates.
READ MORE
